Skip to content

Effects of Soy Protein on Serum paraoxonase1 Activity and Lipoproteins in Postmenopausal Women

Effects of Soy Protein on Serum paraoxonase1 Activity and Lipoproteins in Postmenopausal Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00457262
Enrollment
42
Registered
2007-04-06
Start date
2006-01-31
Completion date
2006-08-31
Last updated
2007-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia, Postmenopausal

Keywords

paraoxonase1 activity, LDL, HDL, postmenopausal women, postmenopausal women and hyperlipidemia

Brief summary

paraoxonase 1 is involved to prevent LDL and HDL oxidation,so increase of it's activity leads to lower risk of coronary heart disease.In postmenopausal women ,we have decrease of paraoxonase1 activity and soy proteins may increase paraoxonase1 activity

Detailed description

In a double blind clinical randomised clinical trial with parallel design this study was done.52 postmenopausal women were randomly assigned to 50 g/d soy protein or placebo for 10 weeks.serum lipoproteins and pon1 activity were measured at baseline and 10th week.There were significant increase in PON! activity and significant decrease in LDL-C,LDL-C/HDL-C,TC/HDL-C and TG/HDL-C in soy group compare to placebo group.

Interventions

PROCEDUREsoy consumption

Sponsors

Iran University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE

Eligibility

Sex/Gender
FEMALE
Age
51 Years to 57 Years
Healthy volunteers
Yes

Inclusion criteria

* Cessation of menes for more than 1 year, elevation for more than 1 year * Elevation of FSH level * Total cholesterol * Triglyceride more than 200 mg/dl

Exclusion criteria

* Chronic disease (heart disease, cancer, diabetes, hepatic, kidney and thyroid disease) * Antihypertensive drugs * Antibiotics * Lipid lowering drugs * Sex hormone treatment * Hysterectomy * Diet rich in soy protein

Design outcomes

Primary

MeasureTime frame
decrease of LDL,increase of HDL,increase of paraoxonase 1

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026